Tian-Li Yue

This inventor holds 4 USPTO granted patents. Top assignees: Boehringer Mannheim Pharmaceuticals Corporation, Smithkline Beecham Corporation, Smithkline Bechman Corporation Limited Partnership No. 1. Active years: 1995-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tian-Li Yue. Retrieved from https://idiyas.com/inventor/tian-li-yue

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 70(Granted Patents)

Company Filing History:

2 out of 2

Boehringer Mannheim Pharmaceuticals Corporation

patents

2 out of 2,198

Smithkline Beecham Corporation

patents

1 out of 1

Smithkline Bechman Corporation Limited Partnership No. 1

patent

4. 1 out of 1

Smithkline Beecham Corporation Limited Prtnrshp No. 1

patent

where one patent can have more than one assignee

Years Active: 1995-2001

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6214854 - Method for inhibiting stress-activated protein kinases (2001-04-10),

2. 6096777 - Method for inhibiting the expression of Fas (2000-08-01),

3. 5405863 - Antioxidant cardioprotective use of, and method of treatment using, (1995-04-11),

4. 5393772 - Use of, and method of treatment using, hydroxycarbazole compounds for (1995-02-28),

Title: Innovations of Tian-Li Yue

Introduction

Tian-Li Yue is a notable inventor based in Havertown, PA, who has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, his work focuses on methods that have the potential to impact medical treatments.

Latest Patents

One of his latest patents is a method for inhibiting stress-activated protein kinases. This invention relates to a method for inhibiting stress-activated protein kinases (SAPKs) which comprises administering to a mammal in need thereof an effective amount of a compound that is a dual non-selective β-adrenoceptor and α-adrenoceptor antagonist. Another significant patent is a method for inhibiting the expression of Fas, which showcases his innovative approach to addressing complex biological challenges.

Career Highlights

Throughout his career, Tian-Li Yue has worked with prominent companies in the pharmaceutical industry, including Boehringer Mannheim Pharmaceuticals Corporation and SmithKline Beecham Corporation. His experience in these organizations has contributed to his expertise and success as an inventor.

Collaborations

Tian-Li Yue has collaborated with notable professionals in his field, including Giora Zeev Feuerstein and Eliot H. Ohlstein. These collaborations have likely enriched his work and expanded the impact of his inventions.

Conclusion

Tian-Li Yue's innovative contributions to pharmaceutical methods demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex biological processes and a dedication to improving health outcomes.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]